ArticleThe Lancet. Respiratory medicine2021
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
Erratum issuedAbstract read
In one paragraph
Article in The Lancet. Respiratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19.Scientific reports · 2023Trial
- COVID-19 knowledge, attitude, and practice in combating TB and COVID-19 in Cameroon.Journal of public health in Africa · 2025Article
- Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012-2022 in Hangzhou, China: implication for public health strategies.BMC public health · 2024Article
- Stigma relating to tuberculosis infection prevention and control implementation in rural health facilities in South Africa - a qualitative study outlining opportunities for mitigation.BMC global and public health · 2024Article
- The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis.Annals of epidemiology · 2024Article
- Article
- The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.PLOS global public health · 2024Article
- Lessons for TB from the COVID-19 response: qualitative data from Brazil, India and South Africa.Public health action · 2023Article
- TB programme stakeholder views on lessons from the COVID-19 response in South Africa.Public health action · 2023Article
- Positive effects of health behaviors acquired during the COVID-19 pandemic process on the prevention of other infectious diseases.Turkish journal of medical sciences · 2023Article
- Review
- Changing patterns of household transmission of tuberculosis in an eastern state of India: The impact of COVID19 pandemic.The Indian journal of tuberculosis · 2022Article
- COVID-19's Impact on Digital Health Adoption: The Growing Gap Between a Technological and a Cultural Transformation.JMIR human factors · 2022Article
- Impact of ventilation and avoidance measures on SARS-CoV-2 risk of infection in public indoor environments.The Science of the total environment · 2022Article
- Perspectives of the General Public Regarding Government Policies in Combating the COVID-19 Pandemic.Cureus · 2022Article
- COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020.BMJ global health · 2022Article
- Tuberculosis in times of COVID-19.Journal of epidemiology and community health · 2022Article
- Non-pharmaceutical interventions during the roll out of covid-19 vaccines.BMJ (Clinical research ed.) · 2021Article
- The impact of COVID-19 on TB: a review of the data.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021Review
- What the science says about lifting mask mandates.Nature · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
13 authors.
Koen Vanden DriesscheDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa; Division of Paediatric Pulmonology, Department of Paediatrics, University Hospital Antwerp, Edegem, Belgium; Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, Netherlands.
Precious Z MahloboDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa.
Rouxjeane VenterDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa.
Judy CaldwellDepartment of Health, City of Cape Town, Cape Town, South Africa.
Karen JenningsDepartment of Health, City of Cape Town, Cape Town, South Africa.
Andreas H DiaconDepartment of Medicine, Stellenbosch University, Cape Town, South Africa; TASK Applied Science, Cape Town, South Africa.
Mark F CottonFamily Clinical Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa.
Ronald de GrootSection Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, Netherlands.
Niel HensFamily Medicine and Population Health (FAMPOP), Centre for Health Economic Research and Modelling Infectious Diseases (CHERMID), and Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Florian M MarxDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa; DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Robin M WarrenDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa.
Hridesh MishraDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa.
Grant TheronDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7550, South Africa. Electronic address: gtheron@sun.ac.za.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Communicable Disease ControlCOVID-19Health PolicyHumansMasksMycobacterium tuberculosisSARS-CoV-2Social StigmaTuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.